Dr. Joseph A. Paydarfar, MD

Dr. Paydarfar practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Paydarfar's NPI, 1700975620, was assigned on October 11, 2006. Dr. Paydarfar graduated from Duke University School of Medicine in 1996. Dr. Paydarfar holds New Hampshire license 11716.

Dr. Paydarfar's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Paydarfar's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Paydarfar is also affiliated with Cheshire Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Paydarfar to 3 more hospitals and 2 medical groups, each named with a free account. Dr. Paydarfar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paydarfar practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Paydarfar's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Paydarfar is licensed in New Hampshire.

CMS data shows 328 Medicare services from Dr. Paydarfar across 7 procedure codes in 2024, for 192 Medicare patients. Medicare paid $36,353 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Dr. Paydarfar in 2024. The largest group is 65 to 74, with 83 patients. 68% of them have high blood pressure, and 60% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paydarfar's median patient age at 69, with 40% women.

In 2024, Dr. Paydarfar wrote 35 Medicare Part D claims for 18 patients. 89% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $186 in total drug cost. In 2017, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Paydarfar for performance year 2024, reported through an alternative payment model (APM). Dr. Paydarfar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Paydarfar, published from 2011 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Head and Neck Neoplasms, Laryngoscopy and Carcinoma, Squamous Cell. Dr. Paydarfar has published most often in Ann Biomed Eng. Dr. Paydarfar's most frequent co-authors are David Pastel, MD, Benoit J. Gosselin, FRCSC, MD and Marc A. Polacco, MD.

CMS Open Payments shows 18 general payments to Dr. Paydarfar from 4 drug and device companies from 2016 to 2025. Education make up the largest share, 64% of the total. Intuitive Surgical, Inc. paid the most, $4,962.

Dr. Paydarfar graduated from Duke University School of Medicine in 1996.